INNOVATION POTENTIAL OF RUSSIAN NORTHERN REGIONS: DEVELOPMENT TRENDS by E.N. Berezikova, E.S. Noskova

Get full text

EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION by A. T. Teplyakov, E. V. Grakova, E. N. Berezikova, S. N. Shilov, K. V. Kopeva, V. V. Kalyuzhin

Get full text

Endothelial dysfunction markers in young patients with silent arterial hypertension by S. D. Mayanskaya, A. R. Antonov, A. A. Popova, E. N. Berezikova, E. B. Luksha, I. I. Volkova

Get full text

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy by A. T. Teplyakov, S. N. Shilov, A. A. Popova, E. N. Berezikova, M. N. Neupokoeva, E. V. Grakova, K. V. Kopeva

Get full text

Predictors of an adverse course of heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome by A. T. Teplyakov, A. V. Yakovlev, S. N. Shilov, N. F. Yakovleva, E. N. Berezikova, E. V. Grakova, K. V. Kopeva, S. D. Mayanskaya

Get full text

Influence of endothelial NO synthase gene polymorphisms on development and prognosis of chronic heart failure by N. F. Yakovleva, S. D. Mayanskaya, A. V. Yakovlev, M. L. Filipenko, E. N. Voronina, E. N. Berezikova, S. N. Shilov, T. I. Zakharova

Get full text

Chronic Heart Failure in Patients with Arterial Hypertension Associated with Obstructive Sleep Apnea Syndrome: Possible Options to Pathogenetic Therapy by A. V. Yakovlev, S. N. Shilov, E. N. Berezikova, N. F. Yakovleva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, I. A. Efremov

Get full text

Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure by A T Tepliakov, S N Shilov, E N Berezikova, A V Efremov, I D Safronov, M G Pustovetova, S D Maianskaia, Iu Iu Torim, R S Karpov

Get full text

Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure by A T Teplyakov, E N Berezikova, S N Shilov, E V Grakova, Yu Yu Torim, A V Efremov, I D Safronov, M G Pustovetova, R S Karpov

Get full text

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases by E. V. Grakova, K. V. Kopeva, S. N. Shilov, E. N. Berezikova, A. A. Popova, M. N. Neupokoeva, E. T. Ratushnyak, V. V. Kalyuzhin, A. T. Teplyakov

Get full text

Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis by S. N. Shilov, E. N. Berezikova, A. A. Popova, E. N. Samsonova, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, A. V. Molokov, I. V. Yakovleva

Get full text

The effect of bisphosphonate therapy on reducing the risk of cardiovascular complications associated with chronic heart failure, type 2 diabetes and osteoporosis in postmenopausal... by A T Teplyakov, E N Berezikova, S N Shilov, A A Popova, E N Samsonova, I V Yakovleva, A V Molokov, E V Grakova, K V Kopeva

Get full text

EVALUATION OF THE ROLE OF HYPERHOMOCYSTEINEMIA AND POLYMORPHISM C677T GENE OF METHYLTETRAHYDROFOLATEREDUCTASE IN DEVELOPMENT OF CHRONIC HEART FAILURE by A. T. Teplyakov, E. N. Berezikova, S. N. Shilov, E. V. Grakova, Yu. Yu. Torim, A. V. Efremov, А. А. Popova, М. G. Pustosvetova, А. Yu. Sabirova, К. V. Kopieva

Get full text

Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis by A. T. Teplyakov, E. N. Berezikova, S. N. Shilov, A. A. Popova, I. V. Yakovleva, A. V. Molokov, E. V. Grakova, K. V. Kopeva, A. V. Svarovskaya, O. V. Garmaeva, Yu. Yu. Torim, E. I. Stepachev, V. V. Kalyuzhin

Get full text